Icariin attenuates β-amyloid-induced neurotoxicity by inhibition of tau protein hyperphosphorylation in PC12 cells

Neuropharmacology

Volumn 59, Issue 6, 2010, Pages 542-550

  Zeng, Ke Wu ^a,b   Ko, Hyeonseok ^a   Yang, Hyun Ok ^a   Wang, Xue Mei ^b  

^a Korea Institute of Science and Technology   (South Korea)

^b PEKING UNIVERSITY   (China)

Author keywords

Amyloid (A ); GSK 3 ; Icariin; PI3K Akt; Tau protein hyperphosphorylation

Indexed keywords

AMYLOID BETA PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; ICARIIN; TAU PROTEIN;

ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION;

AMYLOID BETA-PEPTIDES; ANALYSIS OF VARIANCE; ANIMALS; APOPTOSIS; BLOTTING, WESTERN; CELL SURVIVAL; FLAVONOIDS; FLUORESCENT ANTIBODY TECHNIQUE; NEURONS; PC12 CELLS; PEPTIDE FRAGMENTS; PHOSPHORYLATION; RATS; TAU PROTEINS;

EID: 77956920667     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2010.07.020     Document Type: Article

References (45)

1. Alonso A.C., Grundke-Iqbal I., Iqbal K. Alzheimer's disease hyperphosphorylated tau sequesters normal tau into tangles of filaments and disassembles microtubules. Nat. Med. 1996, 2:783-787.
2. Annika R., Nenad B., Inga V., Bengt W., Rivka R., Richard C.F. Akt activity in Alzheimer's disease and other neurodegenerative disorders. Neuroreport 2004, 15:955-959.
3. Baki L., Shioi J., Wen P., Shao Z., Schwarzman A., Gama-Sosa M., Neve R., Robakis N.K. PS1 activates PI3K thus inhibiting GSK-3 activity and tau overphosphorylation: effects of FAD mutations. EMBO J. 2004, 23:2586-2596.
4. Ballatore C., Lee V.M.Y., Trojanowski J.Q. Tau-mediated neurodegeneration in Alzheimer's disease and related disorders. Nat. Rev. Neurosci. 2007, 8:663-672.
5. Chen P., Gu Z., Liu W., Yan Z. Glycogen synthase kinase 3 regulates N-methyl-d-aspartate receptor channel trafficking and function in cortical neurons. Mol. Pharmacol. 2007, 72:40-51.
6. Chung B.H., Kim J.D., Kim C.K., Kim J.H., Won M.H., Lee H.S., Dong M.S., Ha K.S., Kwon Y.G., Kim Y.M. Icariin stimulates angiogenesis by activating the MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways in human endothelial cells. BBRC 2008, 376:404-408.
7. Cohen P., Holmes C.F.B., Tsukitani Y. Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem. Sci. 1990, 15:98-102.
8. Cuzzocrea S., Mazzon E., Paola R.D., Muià C., Crisafulli C., Dugo L., Collin M., Britti D., Caputi A.P., Thiemermann C. Glycogen synthase kinase-3β inhibition attenuates the degree of arthritis caused by type II collagen in the mouse. Clin. Immunol. 2006, 120:57-67.
9. Eldar-Finkelman H. Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol. Med. 2002, 8:126-132.
10. Fath T., Eidenmüller J., Brandt R. Tau-mediated cytotoxicity in a pseudohyperphosphorylation model of Alzheimer's diseas. J. Neurosci. 2002, 22:9733-9741.
11. Franke T.F., Hornik C.P., Segev L., Shostak G.A., Sugimoto C. PI3K/Akt and apoptosis: size matters. Oncogene 2003, 22:8983-8998.
12. Gharbi S.I., Zvelebil M.J., Shuttleworthe S.J., Hancox T., Saghir N., Timms J.F., Waterfield M.D. Exploring the specificity of the PI3K family inhibitor LY294002. Biochem. J. 2007, 404:15-21.
13. Hanger D.P., Hughes K., Woodgett J.R., Brion J.P., Anderton B.H. Glycogen synthase kinase-3 induces Alzheimer's disease-like phosphorylation of tau: generation of paired helical filament epitopes and neuronal localisation of the kinase. Neurosci. Lett. 1992, 147:58-62.
14. Harris K.A., Oyler G.A., Doolittle G.M., Vincent I., Lehman R.A.W., Kincaid R.L., Billingsley M.L. Okadaic acid induces hyperphosphorylated forms of tau protein in human brain slices. Ann. Neurol. 2004, 33:77-87.
15. Hong M., Chen D.C.R., Klein P.S., Lee V.M.Y. Lithium reduces tau phosphorylation by inhibition of glycogen synthase kinase-3. J. Biol. Chem. 1997, 272:25326-25332.
16. Koizumi H., Yu J., Hashimoto R., Ouchi Y., Okabe T. Involvement of androgen receptor in nitric oxide production induced by icariin in human umbilical vein endothelial cells. FEBS 2010, 584:2440-2444.
17. LaFerla F.M., Oddo S. Alzheimer's disease: aβ, tau and synaptic dysfunction. Trends Mol. Med. 2005, 11:170-176.
18. Lee C.W.C., Lau K.F., Miller C.C.J., Shaw P.C. Glycogen synthase kinase-3[beta]-mediated tau phosphorylation in cultured cell lines. Neuroreport 2003, 14:257-260.
19. Leschik J., Welzel A., Weissmann C., Eckert A., Brandt R. Inverse and distinct modulation of tau-dependent neurodegeneration by presenilin 1 and amyloid-β in cultured cortical neurons: evidence that tau phosphorylation is the limiting factor in amyloid-β-induced cell death. J. Neurochem. 2007, 101:1303-1315.
20. Liang H.R., Vuorela P., Vuorela H., Hiltunen R. Isolation and immunomodulatory effect of flavonol glycosides from Epimedium hunanense. Planta Med. 1997, 63:316-319.
21. Liu R., Zhou X.W., Tanila H., Bjorkdahl C., Wang J.Z., Guan Z.Z., Cao Y., Gustafsson J.A., Winblad B., Pei J.J. Phosphorylated PP2A (tyrosine 307) is associated with Alzheimer neurofibrillary pathology. J. Cell. Mol. Med 2008, 12:241-257.
22. Luo Y., Nie J., Gong Q.H., Lu Y.F., Wu Q., Shi J.S. Protective effect of icariin against learning and memory deficits induced by aluminum in rats. Clin. Exp. Pharmacol. Physiol. 2007, 34:792-795.
23. Mahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-l-benzopyran-4-one (LY294002). J. Biol. Chem. 1994, 269:5241-5248.
24. Martinez A., Alonso M., Castro A., Pérez C., Moreno F.J. First non-ATP competitive glycogen synthase kinase 3β (GSK-3β) inhibitors: thiadiazolidinones (TDZD) as potential drugs for the treatment of Alzheimer's disease. J. Med. Chem. 2002, 45:1292-1299.
25. Meng F.H., Li Y.B., Xiong Z.L., Jiang Z.M., Li F.M. Osteoblastic proliferative activity of Epimedium brevicornum Maxim. Phytomedicine 2005, 12:189-193.
26. Nassif M., Hoppe J., Santin K., Frozza R., Zamin L.L., Simäo F., Horn A.P., Salbego C. β-Amyloid peptide toxicity in organotypic hippocampal slice culture involves Akt/PKB, GSK-3β, and PTEN. Neurochem. Int. 2007, 50:229-235.
27. Nie J., Luo Y., Huang X.N., Lu Y.F., Sun A.S., Gong Q.H., Shi J.S. Protective effect of icariin on learning and memory dysfunction induced by amyloid β-protein fragment 25-35. Chin. J. Pharmacol. Toxicol. 2008, 22:31-37.
28. Nie J., Luo Y., Huang X.N., Gong Q.H., Wu Q., Shi J.S. Icariin inhibits beta-amyloid peptide segment 25-35 induced expression of β-secretase in rat hippocampus. Eur. J. Pharmacol. 2010, 626:213-218.
29. Noble W., Planel E., Zehr C., Olm V., Meyerson J., Suleman F., Gaynor K., Wang L., Francois J.L., Feinstein B., Burns M., Krishnamurthy P., Wen Y., Bhat R., Lewis J., Dickson D., Duff K. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. PNAS 2005, 102:6990-6995.
30. Pan Y., Kong L.D., Xia X., Zhang W.Y., Xia Z.H., Jiang F.X. Antidepressant-like effect of icariin and its possible mechanism in mice. Pharmacol. Biochem. Behav. 2005, 82:686-694.
31. Pap M., Cooper G.M. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. J. Biol. Chem. 1998, 273:19929-19932.
32. Pap M., Cooper G.M. Role of translation initiation factor 2B in control of cell survival by the phosphatidylinositol 3-kinase/Akt/glycogen synthase kinase 3β signaling pathway. Mol. Cell Biol. 2002, 22:578-586.
33. Paudel H.K., Lew J., Ali Z., Wang J.H. Brain proline-directed protein kinase phosphorylates tau on sites that are abnormally phosphorylated in tau associated with Alzheimer's paired helical filaments. J. Biol. Chem. 1993, 268:23512-23516.
34. Pei J.J., Braak E., Braak H., Grundke-Iqbal I., Iqbal K., Winblad B., Cowburn R.F. Distribution of active glycogen synthase kinase 3 beta (GSK-3β) in brains staged for Alzheimer disease neurofibrillary changes. J. Neuropathol. Exp. Neurol. 1999, 58:1010-1019.
35. Shahani N., Subramaniam S., Wolf T., Tackenberg C., Brandt R. Tau aggregation and progressive neuronal degeneration in the absence of changes in spine density and morphology after targeted expression of Alzheimer's disease-relevant tau constructs in organotypic hippocampal slices. J. Neurosci. 2006, 26:6103-6114.
36. Shimohama S. Apoptosis in Alzheimer's disease-an update. Apoptosis 2000, 5:9-16.
37. Spillantini M.G., Goedert M. Tau protein pathology in neurodegenerative diseases. Trends Neurosci. 1998, 21:428-433.
38. Tackenberg C., Brandt R. Divergent pathways mediate spine alterations and cell death induced by amyloid-β, wild-type tau, and R406W tau. J. Neurosci. 2009, 29:14439-14450.
39. Takashima A., Noguchi K., Michel G., Mercken M., Hoshi M., Ishiguro K., Imahori K. Exposure of rat hippocampal neurons to amyloid β peptide (25-35) induces the inactivation of phosphatidyl inositol-3 kinase and the activation of tau protein kinase I/glycogen synthase kinase-3β. Neurosci. Lett. 1996, 203:33-36.
40. Wagner U., Utton M., Gallo J.M., Miller C.C.J. Cellular phosphorylation of tau by GSK-3β influences tau binding to microtubules and microtubule organisation. J. Cell Sci. 1996, 109:1537-1543.
41. 2 in vitro. Pharmacol. Res. 2005, 52:174-182.
42. Wang J.Z., Tung Y.C., Wang Y.P., Li X.T., Iqbal K., Grundke-Iqbal I. Hyperphosphorylation and accumulation of neurofilament proteins in Alzheimer disease brain and in okadaic acid-treated SY5Y cells. FEBS 2001, 507:81-87.
43. Wang Z.F., Li H.L., Li X.C., Zhang Q., Tian Q., Wang Q., Xu H., Wang J.Z. Effects of endogenous β-amyloid overproduction on tau phosphorylation in cell culture. J. Neurochem. 2006, 98:1167-1175.
44. Zhang Y.W., Morita I., Shao G., Yao X.S., Murota S. Screening of anti-hypoxia/reoxygenation agents by an in vitro model. Planta Med. 2000, 66:114-123.
45. Zhao Y., Cui Z., Zhang L. Effect of icariin on the differentiation of HL-60 cells. Zhonghua Zhong Liu Za Zhi 1997, 19:53-55.